Invention Publication
- Patent Title: USE OF MGLUR5 ANTAGONISTS FOR TREATING GAMBLING DISORDER
-
Application No.: US18266917Application Date: 2021-12-09
-
Publication No.: US20240082215A1Publication Date: 2024-03-14
- Inventor: Fabrizio GASPARINI , Baltazar GOMEZ-MANCILLA , John KRYSTAL , Vincent MALATERRE , Stephanie O'MALLEY , Godfrey PEARLSON , Marc POTENZA
- Applicant: Novartis AG , Yale University
- Applicant Address: CH CT Basel
- Assignee: Novartis AG,Yale University
- Current Assignee: Novartis AG,Yale University
- Current Assignee Address: CH Basel; US CT New Haven
- International Application: PCT/IB2021/061506 2021.12.09
- Date entered country: 2023-06-13
- Main IPC: A61K31/404
- IPC: A61K31/404 ; A61P25/30
Abstract:
The present invention relates to the use of mavoglurant in the treatment of gambling disorder. The present invention also relates to the use of mavoglurant in the treatment of gaming disorder.
Information query
IPC分类:
